PENN071i-216-13
| Cell Line Alias | iPS-216-SeV13 |
| Cell Type | Human iPS |
| Disease | None reported |
| Sex | Female |
| Age at Collection | 24 Years |
| Ethnicity | None Reported |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc) |
| Tissue Origin | Blood |
| Provider | University of Pennsylvania - Dr. Daniel Rader |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Lipid Conditions (Dr. Daniel Rader, University of Pennsylvania) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB34946 | Stem Cell Culture Medium (KOSR/MEF) | 16 | Provider | WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocol |
